Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
525,246
-
Share change
-
-50,888
-
Total reported value
-
$26,501,000
-
Price per share
-
$50.43
-
Number of holders
-
13
-
Value change
-
-$2,576,990
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) as of Q2 2018
As of 30 Jun 2018,
NOVOZYMES AS/FI - ADR (NVZMY) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
525,246 shares.
The largest 10 holders included
Parametric Portfolio Associates LLC, BOSTON FINANCIAL MANGEMENT LLC, Lenox Wealth Management, Inc., ZEVIN ASSET MANAGEMENT LLC, Moloney Securities Asset Management, LLC, Boston Common Asset Management, LLC, GARRISON BRADFORD & ASSOCIATES INC, Hemenway Trust Co LLC, PNC Financial Services Group, Inc., and HIGH POINTE CAPITAL MANAGEMENT LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.